Cell and Gene Therapy News

Special T cells that target solid tumors offer potential treatment for pediatric and adult cancersSep 14, 2016
A new study by researchers at Baylor College of Medicine and Texas Children’s Cancer Center has shown promising results for the use of adoptive cell-therapies to treat pediatric and adult solid tumor cancers.
One-time treatment rescues lethal metabolic liver disease in miceAug 30, 2016
Researchers have shown in mice that deleting a gene associated with liver disorder tyrosinaemia type I, they can turn the once deadly illness benign.
T cells that target two tumor surface molecules mitigate tumor escape in mouse model of glioblastomaJul 18, 2016
Researchers show a new strategy, based on targeting specific surface molecules, that eliminates most of the cancer cells in a mouse model of glioblastoma.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.
Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responsesJun 6, 2016
Treating B cell malignancies with the patients’ own T cells modified so as to target specific B cell markers has shown clinical success.
Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancerApr 4, 2016
Baylor College of Medicine researchers have discovered that CTLA-4 is produced and secreted by dendritic cells, which are the ‘generals’ of the T cells in the battle against cancer.
Heslop named director of Center for Cell and Gene TherapyApr 1, 2016
The Baylor College of Medicine Board of Trustees named Dr. Helen Heslop as director of the Center for Cell and Gene Therapy.
Grants support Baylor researchers’ work on immunotherapy for leukemiaOct 2, 2015
Two Baylor researchers have received Translational Research Grants for projects that use immunotherapy approaches to treat leukemia.
Safety switch preserves beneficial effects of cell therapyMay 14, 2015
Researchers have found that a single dose of an otherwise harmless drug can safely control the severe and often lethal side effects associated with haploidentical stem cell transplantation.
Novel cell therapy from 'naïve' cells recognizes, attacks high-risk viruses for first time in cord blood transplant patientsApr 29, 2015
Virus-specific cell therapy used in cord blood transplant patients successfully prevented 3 of the most problematic post-transplant viruses affecting this group of patients – cytomegalovirus, Epstein-Barr virus, and adenovirus.